Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 67 publications
Exosomal EPHA2 transfers metastatic potential by stabilizing TGF-βRI and activating the TGF-β/SMAD3 signaling pathway in breast cancer.
Journal: Cancer biology & medicine
Published: February 24, 2026
Rack1 promotes breast cancer stemness properties and tumorigenesis through the E2F1-SOX2 axis.
Journal: Cancer cell international
Published: January 08, 2025
Macrophage membrane-based biomimetic nanocarrier system for enhanced immune activation and combination therapy in liver cancer.
Journal: Drug delivery and translational research
Published: July 28, 2024
Fructose promotes angiogenesis by improving vascular endothelial cell function and upregulating VEGF expression in cancer cells.
Journal: Journal of experimental & clinical cancer research : CR
Published: April 12, 2023
Comprehensively analysis of splicing factors to construct prognosis prediction classifier in prostate cancer.
Journal: Journal of cellular and molecular medicine
Published: April 08, 2023
RACK1 facilitates breast cancer progression by competitively inhibiting the binding of β-catenin to PSMD2 and enhancing the stability of β-catenin.
Journal: Cell death & disease
Published: March 12, 2023
Chemotherapy induces ACE2 expression in breast cancer via the ROS-AKT-HIF-1α signaling pathway: a potential prognostic marker for breast cancer patients receiving chemotherapy.
Journal: Journal of translational medicine
Published: August 04, 2022
Exosomal EPHA2 derived from highly metastatic breast cancer cells promotes angiogenesis by activating the AMPK signaling pathway through Ephrin A1-EPHA2 forward signaling.
Journal: Theranostics
Published: February 25, 2022
Comprehensive Analysis of Splicing Factor and Alternative Splicing Event to Construct Subtype-Specific Prognosis-Predicting Models for Breast Cancer.
Journal: Frontiers in genetics
Published: July 20, 2021
Last Updated: 09/26/2026